Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
3,068,428
-
Share change
-
+3,068,428
-
Total reported value
-
$22,521,000
-
Price per share
-
$7.34
-
Number of holders
-
13
-
Value change
-
+$22,521,000
-
Number of buys
-
13
Institutional Holders of ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) as of Q3 2018
As of 30 Sep 2018,
ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,068,428 shares.
The largest 10 holders included
683 Capital Management, LLC, TYNDALL CAPITAL PARTNERS L P, EcoR1 Capital, LLC, Point72 Asset Management, L.P., Kepos Capital LP, Vanguard Group Inc, ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and PANAGORA ASSET MANAGEMENT INC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.